Drug Profile
Research programme: central nervous system disorder therapeutics - Johnson & Johnson Innovation/Peking University
Alternative Names: G-protein-coupled receptors (GPCRs) agonists and antagonists - Johnson and Johnson Innovation/Peking UniversityLatest Information Update: 28 Nov 2018
Price :
$50
*
At a glance
- Originator Johnson & Johnson Innovation; Peking University
- Class
- Mechanism of Action G protein-coupled receptor agonists; G protein-coupled receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported CNS disorders
Most Recent Events
- 28 Nov 2018 No recent reports of development identified for research development in CNS-disorders in China
- 28 Oct 2014 Early research in CNS disorders in China (unspecified route)